↓ Skip to main content

Dove Medical Press

Article Metrics

Profile of vildagliptin in type 2 diabetes: efficacy, safety, and patient acceptability

Overview of attention for article published in Therapeutics and Clinical Risk Management, May 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#15 of 1,090)
  • High Attention Score compared to outputs of the same age (96th percentile)

Mentioned by

news
8 news outlets
blogs
1 blog

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
44 Mendeley
Title
Profile of vildagliptin in type 2 diabetes: efficacy, safety, and patient acceptability
Published in
Therapeutics and Clinical Risk Management, May 2013
DOI 10.2147/tcrm.s30071
Pubmed ID
Authors

Chang Yu Pan, Wang

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 2%
Unknown 43 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 20%
Student > Postgraduate 7 16%
Other 6 14%
Student > Bachelor 6 14%
Researcher 5 11%
Other 8 18%
Unknown 3 7%
Readers by discipline Count As %
Medicine and Dentistry 21 48%
Pharmacology, Toxicology and Pharmaceutical Science 5 11%
Nursing and Health Professions 4 9%
Agricultural and Biological Sciences 4 9%
Biochemistry, Genetics and Molecular Biology 2 5%
Other 4 9%
Unknown 4 9%

Attention Score in Context

This research output has an Altmetric Attention Score of 68. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 December 2020.
All research outputs
#361,351
of 16,726,235 outputs
Outputs from Therapeutics and Clinical Risk Management
#15
of 1,090 outputs
Outputs of similar age
#11,705
of 316,500 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#1
of 1 outputs
Altmetric has tracked 16,726,235 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,090 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 316,500 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them